In addition to all of your molecular testing needs, GenPath also provides state-of-the-art coagulation testing services for your patients. Over 100 advanced assays and panels are available and analyzed by our expert in-house medical staff led by De-Hui Wayne Ku, PhD.To view a comprehensive listing of all tests offered by GenPath, please visit our Test Directory or download our Coagulation Requisition.
SAMPLE OF SPECIAL COAGULATION TESTS OFFERED
- Complete Blood Count (CBC)Complete blood count (CBC) testing is beneficial in detecting cancer and monitoring cancer treatment in patients. CBC tests can be used as a diagnostic tool for leukemia, anemia, and other hematological disorders. A CBC measures the amount and ratio of blood cell types circulating in the bloodstream. Changes in these numbers can indicate disease progression or response to treatment.
- PT, PTTProthrombin time (PT) and partial thromboplastin time (PTT) tests evaluate hemostasis . They measure coagulation factor efficiency by the amount of time it takes for plasma to clot PT and PTT can help monitor cancer treatment and anticoagulant medications.
- Thrombophilia AssessmentThrobophilia assessments are useful in monitoring patients more susceptible to excessive clotting. For example, ponatinib, a FDA approved therapy for CML and Ph+ ALL, can increase the risk of developing blood clots in the blood vessels* so the throbophilia assessment will help with treatment management for this patient population. *Adult CML and Ph+ ALL patients with T3151 mutations or for whom no other TKI is indicated
- D-Dimer TestThe D-Dimer test is used to rule out abnormal blood clotting. It measures the amount of D-Dimer released when a blood clot breaks up. A study in Haematologica found that high D-Dimer levels are associated with a poor prognosis for cancer patients (2012) due to activating the patient€™s hemostatic system.
SPECIAL COAGULATION PANELS
Abnormal aPTT Assessment
Abnormal PT & aPTT Assessment
Abnormal PT Solely
Antiphospholipid Antibody & Lupus Inhibitor Assessment – Basic
Antiphospholipid Antibody & Lupus Inhibitor Assessment – Expanded
Arterial & Atherothrombotic Risk – Basic
Arterial & Atherothrombotic Risk – Expanded
Bleeding Diathesis Evaluation
General Thrombophilia Assessment for Inherited & Acquired Disorders
Fibrinolytic Evaluation – Standard
For Specific Factor Inhibitor
Lupus Inhibitor Screen
Hyperactive Coagulation Panel
Pregnancy Thrombophilia Assessment
Venous Prothrombotic Risk Factor
von Willebrand Screen – Basic
von Willebrand Screen – Expanded